دورية أكاديمية
Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial
| العنوان: | Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial |
|---|---|
| المؤلفون: | Anouk S. Schuit, Karen Holtmaat, Veerle M. H. Coupé, Simone E. J. Eerenstein, Josée M. Zijlstra, Corien Eeltink, Annemarie Becker-Commissaris, Lia van Zuylen, Myra E. van Linde, C. Willemien Menke-van der Houven van Oordt, Dirkje W. Sommeijer, Nol Verbeek, Koop Bosscha, Rishi Nandoe Tewarie, Robert-Jan Sedee, Remco de Bree, Alexander de Graeff, Filip de Vos, Pim Cuijpers, Irma M. Verdonck-de Leeuw, Femke Jansen |
| المصدر: | Current Oncology, Vol 29, Iss 9, Pp 6186-6202 (2022) |
| بيانات النشر: | MDPI AG, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| مصطلحات موضوعية: | palliative care, eHealth, cost-utility analysis, cost evaluation, incurable cancer, quality of life, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | Evidence on the cost-effectiveness of eHealth in palliative care is scarce. Oncokompas, a fully automated behavioral intervention technology, aims to support self-management in cancer patients. This study aimed to assess the cost-utility of the eHealth application Oncokompas among incurably ill cancer patients, compared to care as usual. In this randomized controlled trial, patients were randomized into the intervention group (access to Oncokompas) or the waiting-list control group (access after three months). Healthcare costs, productivity losses, and health status were measured at baseline and three months. Intervention costs were also taken into account. Non-parametric bootstrapping with 5000 replications was used to obtain 95% confidence intervals around the incremental costs and quality-adjusted life years (QALYs). A probabilistic approach was used because of the skewness of cost data. Altogether, 138 patients completed the baseline questionnaire and were randomly assigned to the intervention group (69) or the control group (69). In the base case analysis, mean total costs and mean total effects were non-significantly lower in the intervention group (−€806 and −0.01 QALYs). The probability that the intervention was more effective and less costly was 4%, whereas the probability of being less effective and less costly was 74%. Among patients with incurable cancer, Oncokompas does not impact incremental costs and seems slightly less effective in terms of QALYs, compared to care as usual. Future research on the costs of eHealth in palliative cancer care is warranted to assess the generalizability of the findings of this study. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1718-7729 1198-0052 |
| العلاقة: | https://www.mdpi.com/1718-7729/29/9/486Test; https://doaj.org/toc/1198-0052Test; https://doaj.org/toc/1718-7729Test |
| DOI: | 10.3390/curroncol29090486 |
| الوصول الحر: | https://doaj.org/article/3a47e0cbe6194f9ca1f1a13d7602a847Test |
| رقم الانضمام: | edsdoj.3a47e0cbe6194f9ca1f1a13d7602a847 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 17187729 11980052 |
|---|---|
| DOI: | 10.3390/curroncol29090486 |